Filing Details
- Accession Number:
- 0001104659-25-014257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-14 16:55:57
- Reporting Period:
- 2025-02-12
- Filing Date:
- 2025-02-14
- Accepted Time:
- 2025-02-14 16:55:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649904 | Rhythm Pharmaceuticals Inc. | RYTM | Pharmaceutical Preparations (2834) | 462159271 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801372 | Kayden Jennifer Lee | C/O Rhythm Pharmaceuticals, Inc. 222 Berkeley Street, 12Th Floor Boston MA 02116 | Evp, Head Of North America | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-02-12 | 600 | $56.39 | 4,813 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-12 | 10 | $56.41 | 4,803 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-12 | 1,205 | $56.39 | 3,598 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-13 | 1,205 | $58.00 | 2,393 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2024.
Billionaire Hedge Funds
